Doctor/Provider Profile

Scott M. Lindhorst, M.D.

Provider Image
  • Assistant Professor
Degree M.D.
School M.D. awarded by University of South Alabama College of Medicine, 2005
  • University of Alabama at Birmingham Medical Center
  • University of Alabama at Birmingham Medical Center
  • Duke University
Board Certification
  • Internal Medicine
  • Internal Medicine: Hematology
  • Internal Medicine: Medical Oncology
  • United Council for Neurologic Subspecialties: Neuro-Oncology
  • Neurosurgery
  • Hematology/Oncology
Clinical Interests
  • Central nervous system lymphomas
  • Head and neck cancers
  • Lymphomas
  • Neuro-oncology
  • Primary brain tumors
Accepts New Patients Yes
To request an appointment call our representatives at 843-792-1414


Rutledge Tower
135 Rutledge Ave.
Charleston, SC 29425
Map & Directions
MUSC Health East Cooper
1600 Midtown Ave.
Mount Pleasant, SC 29464
Map & Directions
Hollings Cancer Center
86 Jonathan Lucas St.
Charleston, SC 29425
Map & Directions


Scott Lindhorst, MD, joined the Division of Hematology/Oncology effective August 1, 2013 as an Assistant Professor.  He also holds a dual appointment as an Assistant Professor in the Division of Neurosurgery. 

Dr. Lindhorst received his Bachelor of Science in Microbiology, with a minor in Chemistry, from the University of Florida in 2001 followed by his Medical Degree from the University of South Alabama College of Medicine in 2005.  He completed a residency in Internal Medicine followed by a fellowship in Hematology and Medical Oncology at the University of Alabama at Birmingham School of Medicine.  He also completed a fellowship in Neuro-Oncology at Duke University Medical Center in 2013.  Dr. Lindhorst received clinical trials training at Massachusetts General Hospital, focusing on patients with amyotrophic lateral sclerosis. 

He is board-certified in General Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine.  He is also board-certified in Neuro-Oncology by the United Council for Neurologic Subspecialties. 

His practice will focus on patients with primary and metastatic malignancies of the central nervous system, as well as patients with head and neck cancers.  Dr. Lindhorst looks forward to expanding his involvement in clinical trials and aiding in the growing need for new cancer treatments.

Multimedia Library

Edit Profile